News

Search EMA's news announcements

Resultaten (3841)

Benefits of ifosfamide solutions continue to outweigh risks EMA’s safety committee (PRAC) has concluded that the benefits of ifosfamide solutions for infusion

12 maart 2021

NewsHumanPharmacovigilanceReferrals

COVID-19 Vaccine AstraZeneca: PRAC investigating cases of thromboembolic events - vaccine’s benefits currently still outweigh risks - Update

11 maart 2021

NewsHumanCOVID-19Vaccines

EMA recommends COVID-19 Vaccine Janssen for authorisation in the EU

11 maart 2021

NewsHumanCOVID-19Vaccines

EMA website briefly unavailable on 15 March 2021

11 maart 2021

NewsCorporate

EMA starts rolling review of Eli Lilly antibodies bamlanivimab and etesevimab for COVID-19

11 maart 2021

NewsHumanCOVID-19Medicines

COVID-19 Vaccine AstraZeneca: PRAC preliminary view suggests no specific issue with batch used in Austria

10 maart 2021

NewsHumanCOVID-19Vaccines

EMA issues advice on use of antibody combination (bamlanivimab / etesevimab)

5 maart 2021

NewsHumanCOVID-19Medicines

EMA website briefly unavailable on 8 March 2021

5 maart 2021

NewsCorporate

EMA starts rolling review of the Sputnik V COVID-19 vaccine

4 maart 2021

NewsHumanCOVID-19Vaccines

EMA review of regdanvimab for COVID-19 to support national decisions on early use

2 maart 2021

NewsHumanCOVID-19Medicines